Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 2,735 | 3,425 | 3,082 | 2,810 | 2,470 |
| Operating Income | -2,735 | -3,425 | -3,082 | -2,810 | -2,470 |
| Other Income | 6 | 40 | 72 | 83 | 65 |
| Pre-tax Income | -2,729 | -3,385 | -3,010 | -2,726 | -2,405 |
| Net Income Continuous | -2,729 | -3,385 | -3,010 | -2,726 | -2,405 |
| Net Income | $-2,729 | $-3,385 | $-3,010 | $-2,726 | $-2,405 |
| EPS Basic Total Ops | -18.03 | -25.75 | -25.25 | -27.75 | -36.75 |
| EPS Basic Continuous Ops | -18.12 | -25.83 | -25.23 | -27.63 | -36.66 |
| EPS Diluted Total Ops | -18.03 | -25.75 | -25.25 | -27.75 | -36.75 |
| EPS Diluted Continuous Ops | -18.12 | -25.83 | -25.23 | -27.63 | -36.66 |
| EPS Diluted Before Non-Recurring Items | -18.50 | -25.75 | -25.25 | N/A | N/A |
| EBITDA(a) | $-2,734 | $-3,425 | $-3,082 | $-2,810 | $-2,469 |